122 related articles for article (PubMed ID: 2433429)
1. Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210.
Akman SA; Doroshow JH; Dietrich MF; Chlebowski RT; Block JS
J Pharmacol Exp Ther; 1987 Feb; 240(2):486-91. PubMed ID: 2433429
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool.
Akman SA; Dietrich M; Chlebowski R; Limberg P; Block JB
Cancer Res; 1985 Nov; 45(11 Pt 1):5257-62. PubMed ID: 2996758
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
Chlebowski RT; Dietrich M; Akman S; Block JB
Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K3 preferentially inhibits stimulation of phospholipase D-mediated hydrolysis of phosphatidylethanolamine by protein kinase C activators in NIH 3T3 fibroblasts.
Tomono M; Kiss Z
Arch Biochem Biophys; 1994 Oct; 314(1):217-23. PubMed ID: 7944397
[TBL] [Abstract][Full Text] [Related]
5. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
Parekh H; Chavan S; Chitnis M
Anticancer Drugs; 1991 Apr; 2(2):159-68. PubMed ID: 1683589
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol.
Ishii T; Hishinuma I; Bannai S; Sugita Y
J Cell Physiol; 1981 May; 107(2):283-93. PubMed ID: 7251686
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells.
Wagner BA; Buettner GR; Burns CP
Arch Biochem Biophys; 1996 Oct; 334(2):261-7. PubMed ID: 8900400
[TBL] [Abstract][Full Text] [Related]
8. Menadione toxicity in two mouse liver established cell lines having striking genetic differences in quinone reductase activity and glutathione concentrations.
Liu RM; Nebert DW; Shertzer HG
Toxicol Appl Pharmacol; 1993 Sep; 122(1):101-7. PubMed ID: 7690996
[TBL] [Abstract][Full Text] [Related]
9. The synergistic action of the copper chelator bathocuproine sulphonate and cysteine in enhancing growth of L1210 cells in vitro.
Ishii T; Bannai S
J Cell Physiol; 1985 Oct; 125(1):151-5. PubMed ID: 4044667
[TBL] [Abstract][Full Text] [Related]
10. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
11. Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.
Su YZ; Duarte TE; Dill PL; Weisenthal LM
Cancer Treat Rep; 1987 Jun; 71(6):619-25. PubMed ID: 3581100
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
13. Identification of the bromosulfophthalein-sensitive efflux route for methotrexate as the site of action of vincristine in the vincristine-dependent enhancement of methotrexate uptake in L1210 cells.
Henderson GB; Tsuji JM
Cancer Res; 1988 Nov; 48(21):5995-6001. PubMed ID: 2844396
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.
Pera PJ; Kramer DL; Sufrin JR; Porter CW
Cancer Res; 1986 Mar; 46(3):1148-54. PubMed ID: 3080234
[TBL] [Abstract][Full Text] [Related]
16. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
[TBL] [Abstract][Full Text] [Related]
17. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
18. Anti-mitochondrial effects of bisethyl polyamines in mammalian cells.
Snyder RD; Beach DC; Loudy DE
Anticancer Res; 1994; 14(2A):347-56. PubMed ID: 8017833
[TBL] [Abstract][Full Text] [Related]
19. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
Cory AH; Cory JG
Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
